Zhang, T., Woldu, S. L., Lee, M., Qin, Q., Cole, S., Arafat, W., Jiang, C., Wang, J., Courtney, K. D., DeVilbiss, A., McGuire, M., Hannan, R., Yang, D. X., Garant, A., Tachibana, I., Gaston, K., Wang, A. Z., Margulis, V., Lotan, Y., Desai, N. B. (2025). Neoadjuvant stereotactic radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4623